Clearview Wealth Advisors’s Axcelis ACLS Stock Holding History

Clearview Wealth Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200	Closed	-$15K	–	598
2021 Q4	$15K	Buy	+200	New	+$11.8K	0.01%	358

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearview Wealth Advisors's ACLS Position: Q1 2022 in Review

Clearview Wealth Advisors sold out of Axcelis (ACLS) in Q1 2022, closing a stake of 200 shares — an estimated $15K sold.

Clearview Wealth Advisors first reported a position in ACLS in Q4 2021 and held it in 1 quarter. The position peaked at $15K in Q4 2021. 290 funds tracked by Wall St. Rank hold ACLS as of Q1 2022.

Clearview Wealth Advisors reported no remaining Axcelis position as of Q1 2022 after selling out during the quarter.
Clearview Wealth Advisors sold 200 Axcelis shares in Q1 2022, an estimated $15K.
Clearview Wealth Advisors first reported a position in Axcelis in Q4 2021 and held it in 1 quarter.
Clearview Wealth Advisors's Axcelis position peaked at $15K in Q4 2021.
290 funds tracked by Wall St. Rank held Axcelis as of Q1 2022.

Based on Clearview Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.